Clinical trial
Use of Hair to Diagnose Breast Cancer
NCT00419679 · Fermiscan Ltd, Industry · Unknown status
Key facts
| NCT number | NCT00419679 |
|---|---|
| Title | Use of Hair to Diagnose Breast Cancer |
| Official title | A Prospective Blinded Study to Evaluate and Characterise an Assay for the Diagnosis of Breast Cancer Using Synchrotron-Derived X-Ray Diffraction of Hair Fibres. |
| Lead sponsor | Fermiscan Ltd, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Procedure |
| Interventions | x-ray diffraction of human hair |
| Enrollment | 3,600 |
| Start date | Dec 1, 2006 |
| First posted | Jan 9, 2007 |
| Last update posted | Jan 9, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: